Liav Abraham

Stock Analyst at Citigroup

(0.86)
# 3,973
Out of 5,180 analysts
14
Total ratings
50%
Success rate
-11.86%
Average return

Stocks Rated by Liav Abraham

Teva Pharmaceutical Industries
Apr 11, 2019
Maintains: Buy
Price Target: $27$23
Current: $30.12
Upside: -23.64%
Abeona Therapeutics
Nov 13, 2018
Maintains: Buy
Price Target: $800$700
Current: $4.48
Upside: +15,525.00%
DBV Technologies
Oct 2, 2017
Maintains: Buy
Price Target: $430$570
Current: $20.98
Upside: +2,616.87%